Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
767 EUR | +0.65% | +3.90% | +45.75% |
06-03 | Eli Lilly: encouraging data for olomorasib | CF |
06-03 | Structure Therapeutics' obesity drug meets main goal in mid-stage study | RE |
MarketScreener Strategies
Pharmaceutical companies still have the upper hand | July 01, 2022 at 08:32 am |
- Stock Market
- Equities
- LLY Stock
- LLY Stock
- News Eli Lilly and Company
- MarketScreener Strategies